Publications in collaboration with researchers from Temple University (9)

2025

  1. Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program

    Schizophrenia Bulletin Open, Vol. 6, Núm. 1

  2. Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program

    Schizophrenia, Vol. 11, Núm. 1

  3. Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program

    Schizophrenia Bulletin Open, Vol. 6, Núm. 1

  4. Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program

    Schizophrenia, Vol. 11, Núm. 1

  5. The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program

    Schizophrenia, Vol. 11, Núm. 1

  6. The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures

    Schizophrenia, Vol. 11, Núm. 1

2024

  1. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

    Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512

  2. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

    Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272

2021

  1. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit

    Schizophrenia Research, Vol. 227, pp. 10-17